We reviewed the science, listened to the specialists, and acted. BARDA is terminating 22 mRNA vaccine growth investments as a result of the information present these vaccines fail to guard successfully in opposition to higher respiratory infections like COVID and flu. We’re shifting that funding towards… pic.twitter.com/GPKbuU7ywN
— Secretary Kennedy (@SecKennedy) August 5, 2025
- Advertisement -